The I/D polymorphism of angiotensin-converting enzyme gene but not the angiotensinogen gene is associated with insulin response to oral glucose in Japanese

Proceedings of the Society for Experimental Biology and Medicine

Volumn 220, Issue 1, 1999, Pages 46-51

  Cong, Nguyen Duc ^a   Hamaguchi, Kazuyuki ^a   Saikawa, Tetsunori ^a   Hara, Masahide ^a   Sakata, Toshiie ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; INSULIN RESPONSE; INSULIN SENSITIVITY; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST;

EID: 0442289642     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-220-44343     Document Type: Article

References (47)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990.
2. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202, 1994.
3. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992.
4. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, Banchieri N, Fortina P, Danesino C, Specchia G. Angiotensin-converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 74:584-591, 1995.
5. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, Nakata Y, Higashino Y, Fujii K, Mikami H, Miki T, Ogihara T. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 25:950-953, 1995.
6. Gardemann A, Weiß T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, Tillmanns H, Waas W, Haberbosch W. Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation 92:2796-2799, 1995.
7. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, Passa P, Forguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in nondependent diabetes mellitus. Proc Natl Acad Sci USA 91:3662-3665, 1994.
8. Cong ND, Hamaguchi K, Saikawa T, Hara M, Sakata T. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese. Am J Med Sci 316:339-344, 1998.
9. Caulfield M, Newell-Price J. The angiotensin-converting enzyme in cardiovascular disease. Br Heart J 74:207-208, 1995.
10. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992.
11. Bloem LJ, Mantunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948-953, 1995.
12. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, Horiuchi M, Pratt RE, Dzau VJ, MacMahon S. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603, 1995.
13. Kamitani A, Rakugi H, Higaki J, Zhao Y, Mikami H, Miki T, Ogihara T. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 8:521-524, 1994.
14. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285-1287, 1994.
15. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 237:175-180, 1995.
16. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H. Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 346:515 (Letter), 1995.
17. Hegele RA, Brunt H, Connelly PW. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 92:1089-1093, 1995.
18. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark A. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633, 1994.
19. Chrostowska M, Winnicki M, Szczech R, Narkiewicz K, Bigda J, Pawlowski R, Krupa-Wojciechowska B. Relation between genetic variation at the angiotensinogen locus and waist-hip ratio, body mass index in normotensive subjects. Am J Hypertens 10:34A, 1997.
20. Katsuya T, Horiuchi M, Chen Y-DI, Koike G, Pratt RE, Dzau VJ, Reaven GM. Relation between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dislipidemia. Arterioscler Thromb Vasc Biol 15:779-782, 1995.
21. Chiu KC, MacCarthy JE. The insertion allele at the angiotensin-converting enzyme gene locus is associated with insulin resistance. Metabolism 46:395-399, 1997.
22. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphies SE, Yudkin JS. The insertion allele of the ACE gene I/D polymorphism, a candidate gene for insulin resistance? Circulation 92:3390-3393, 1995.
23. Kosaka K, Kuzuya T, Hagura R. Insulin secretory response in Japanese type 2 (noninsulin-dependent) diabetic patients. Diabetes Res Clin Pract 24(Suppl):S101-S110, 1994.
24. Report of a WHO study group: Diabetes mellitus. WHO Tech Rep Ser 727:1-113, 1985.
25. Report of a WHO Expert Committee: Arterial hypertension. WHO Tech Rep Ser 628:7-56, 1978.
26. Kimura A, Sasazuki T. Eleventh international histocompatibility workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, Eds. HLA 1991 Vol. I. Oxford: Oxford University Press, pp397-419, 1992.
27. McIntyre N, Holdsworth CD, Turner DS. Intestinal factors in the control of insulin secretion. J Clin Endocrinol Metab 25:1317-1323, 1965.
28. Reaven GM, Greenfield MS, Mondon CE, Rosenthal M, Wright D, Reaven EP. Does insulin removal rate from plasma decline with age? Diabetes 31:670-673, 1982.
29. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Rubenstein AG, Unger RH, Anders R. Feedback inhibition of insulin secretion by insulin: Relation to the hyperinsulinemia of obesity. N Engl J Med 306:1196-1202, 1982.
30. Hollenbeck CB, Chen N, Chen Y-D I, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 33:460-463, 1984.
31. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992.
32. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 20:1433, 1992.
33. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic association with human longevity at the apoE and ACE loci. Nature Genet 6:29-32, 1994.
34. Hibberd ML, Millward BA, Demaine AG. The angiotensin I-converting enzyme (ACE) locus is strongly associated with age and duration of diabetes in patients with type 1 diabetes. J Diabetes Complciations 11:2-8, 1997.
35. Townsend RR, DiPette D. Pressor doses of angiotensin II increase insulin-mediated glucose uptake in normotensive men. Am J Physiol 265:E362-E366, 1993.
36. Buchanan TA, Thawani H, Kades W, Modrall JG, Weaver FA, Laurel C, Poppiti R, Xiang A, Hsueh W. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism. J Clin Invest 92:720-726, 1993.
37. Widgren BR, Urbananvicius V, Wikstrand J, Attvall S, Persson B. Low-dose angiotensin II increases glucose deposition rate during euglycemic hyperinsulinemia. Am J Hypertens 6:892-895, 1993.
38. Morris AD, Donnelly R. Angiotensin II: An insulin-sensitizing vasoactive hormone? J Clin Endocrinol Metab 81:1303-1306, 1996.
39. 2+-sensitive protein kinase in response of hepatocytes to angiotensin II and vasopressin. J Biol Chem 259:3283-3292, 1984.
40. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells: Paracrine role of protacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 135:2030-2036, 1994.
41. Smrcka AV, Helper JR, Brown KO, Sternweis PC. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251:804-807, 1991.
42. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G. Catopril enhances insulin responsiveness of forearm muscle tissue in noninsulin-dependent diabetes mellitus. Eur J Clin Invest 17:448-454, 1987.
43. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and catopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 321:868-873, 1989.
44. Allemann Y, Baumann S, Jost M, Ferrari P, Shaw S, Riesen W, Weidmann P. Insulin sensitivity in normotensive subjects during angiotensin-converting enzyme inhibition with fosinopril. Eur J Clin Pharmacol 42:275-280, 1992.
45. Berntorp K, Lindgarde F, Mattiasson I. Long-term effects on insulin sensitivy and sodium transport in glucose-tolerant hypertensive subjects when β-blockade is replaced by captopril treatment. J Hum Hypertens 6:291-298, 1992.
46. Townsend RR, Zhao HW. Plasma-renin activity and insulin sensitivity in normotensive subjects. Am J Hypertens 7:894-898, 1992.
47. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1:72-75, 1992.